APTO
Price
$0.21
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
12.54M
ATNM
Price
$1.40
Change
+$0.18 (+14.75%)
Updated
Jan 17 closing price
Capitalization
43.67M
55 days until earnings call
Ad is loading...

APTO vs ATNM

Header iconAPTO vs ATNM Comparison
Open Charts APTO vs ATNMBanner chart's image
Aptose Biosciences
Price$0.21
Change-$0.00 (-0.00%)
Volume$264.33K
Capitalization12.54M
Actinium Pharmaceuticals
Price$1.40
Change+$0.18 (+14.75%)
Volume$457.77K
Capitalization43.67M
APTO vs ATNM Comparison Chart
Loading...
APTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APTO vs. ATNM commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTO is a Hold and ATNM is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (APTO: $0.21 vs. ATNM: $1.40)
Brand notoriety: APTO and ATNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APTO: 3% vs. ATNM: 134%
Market capitalization -- APTO: $12.54M vs. ATNM: $43.67M
APTO [@Biotechnology] is valued at $12.54M. ATNM’s [@Biotechnology] market capitalization is $43.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTO’s FA Score shows that 0 FA rating(s) are green whileATNM’s FA Score has 0 green FA rating(s).

  • APTO’s FA Score: 0 green, 5 red.
  • ATNM’s FA Score: 0 green, 5 red.
According to our system of comparison, APTO is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTO’s TA Score shows that 4 TA indicator(s) are bullish while ATNM’s TA Score has 4 bullish TA indicator(s).

  • APTO’s TA Score: 4 bullish, 3 bearish.
  • ATNM’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both APTO and ATNM are a good buy in the short-term.

Price Growth

APTO (@Biotechnology) experienced а -2.77% price change this week, while ATNM (@Biotechnology) price change was +9.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

APTO is expected to report earnings on Aug 10, 2023.

ATNM is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNM($43.7M) has a higher market cap than APTO($12.5M). ATNM YTD gains are higher at: 11.111 vs. APTO (-5.060). APTO has higher annual earnings (EBITDA): -35.78M vs. ATNM (-44.15M). ATNM has more cash in the bank: 78.7M vs. APTO (2.9M). ATNM has less debt than APTO: ATNM (1.71M) vs APTO (10.7M). ATNM has higher revenues than APTO: ATNM (81K) vs APTO (0).
APTOATNMAPTO / ATNM
Capitalization12.5M43.7M29%
EBITDA-35.78M-44.15M81%
Gain YTD-5.06011.111-46%
P/E RatioN/AN/A-
Revenue081K-
Total Cash2.9M78.7M4%
Total Debt10.7M1.71M625%
FUNDAMENTALS RATINGS
APTO vs ATNM: Fundamental Ratings
APTO
ATNM
OUTLOOK RATING
1..100
8873
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6593
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATNM's Valuation (74) in the Biotechnology industry is in the same range as APTO (90). This means that ATNM’s stock grew similarly to APTO’s over the last 12 months.

ATNM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as APTO (100). This means that ATNM’s stock grew similarly to APTO’s over the last 12 months.

ATNM's SMR Rating (98) in the Biotechnology industry is in the same range as APTO (100). This means that ATNM’s stock grew similarly to APTO’s over the last 12 months.

APTO's Price Growth Rating (65) in the Biotechnology industry is in the same range as ATNM (93). This means that APTO’s stock grew similarly to ATNM’s over the last 12 months.

APTO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that APTO’s stock grew similarly to ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APTOATNM
RSI
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
78%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
74%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
68%
Bearish Trend 5 days ago
88%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
89%
View a ticker or compare two or three
Ad is loading...
APTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

APTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, APTO has been loosely correlated with LCTX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if APTO jumps, then LCTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTO
1D Price
Change %
APTO100%
+3.33%
LCTX - APTO
35%
Loosely correlated
+2.80%
AADI - APTO
32%
Poorly correlated
-4.79%
ATNM - APTO
26%
Poorly correlated
+14.75%
HUMA - APTO
26%
Poorly correlated
-1.56%
ORMP - APTO
25%
Poorly correlated
-1.72%
More

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with GBIO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
+14.75%
GBIO - ATNM
47%
Loosely correlated
+0.18%
AURA - ATNM
40%
Loosely correlated
+1.30%
XNCR - ATNM
36%
Loosely correlated
-3.94%
PRLD - ATNM
36%
Loosely correlated
+2.94%
PGEN - ATNM
36%
Loosely correlated
N/A
More